D. Anagnostopoulos et al. / Bioorg. Med. Chem. Lett. 15 (2005) 2766–2770
2769
as inhibitors of this path.24 t-AA was added at
several concentrations to the platelet suspension
(2.5 · 108 cells/mL) and the results are shown in Figure
4. Control aggregation curves with platelet aggregation
factor PAF (4.0 · 10ꢀ10 M) and thrombin (0.5 U/mL)
were also obtained after preincubation with ethanol
for 1 min. t-AA induced rabbit platelet aggregation in
a concentration higher than 2.5 · 10ꢀ4 M. At high,
non-physiological concentrations, cell viability was al-
ways checked without detecting any toxicity or lysis of
platelets. In Figure 4, runs b, c, and d correspond
to 18%, 63%, and 78% aggregation, respectively. At
concentration of 1.5 · 10ꢀ4 M (run a), it could be also
observed that t-AA induces a shape change on rabbit
platelets. Aggregation was not 100% reversible even at
concentrations that induce a small aggregation (e.g.,
2.5 · 10ꢀ4 M). When thrombin (0.5 U/mL) was added
after desaggregation, platelets were activated again and
aggregated irreversibly, suggesting that the high concen-
trations of t-AA were not toxic. For comparison, under
the same experimental conditions, 4.0 · 10ꢀ10 M
PAF and 0.5 U/mL thrombin induced 78% and 67%
platelet aggregation, respectively, whereas AA induced
platelet aggregation at a 10 times lower concentration
(not shown). t-AA activity was also assayed on the
PAF-induced aggregation of rabbit platelets and Table
1 shows the results of different concentrations. t-AA
was found to be inactive under the same experimental
conditions (not shown).
In conclusion, we have described a straightforward and
simple access to all-trans PUFA molecules and in partic-
ular, t-AA was prepared and tested for rabbit platelet
aggregation showing to be active only at high concentra-
tions (>10ꢀ4 M). More interestingly, at micromolar con-
centrations it caused inhibition of aggregation induced
by the strong platelet agonist PAF, which was not pre-
dictable from the known behavior of other trans-mono-
unsaturated fatty acids, and apparently it could be due
to the unique geometry of the polyunsaturated molecule.
Indeed, fatty acid structural modifications can lead to a
change in the biological activity and the presence of
trans double bonds is known to confer a more linear
molecular shape, compared to the cis configuration,
which usually forms a kink in the carbon atom chain.
All-trans fatty acids appear to be interesting candidates
for a chemical biology approach investigating the molec-
ular mechanism of PAF-induced platelet aggregation,
which is currently under study.
Acknowledgements
This work was supported in part by the European Com-
munityÕs Human Potential Program under contract
HPRN-CT-2002-00184 [SULFRAD], by HPMF-CT-
2001-01313 (Marie Curie individual fellowship to A. Sa-
madi), and by the University of Athens Special Account
for Research Grants (70/4/3351).
caused inhibition of
a
4 · 10ꢀ10 M PAF-induced
aggregation in a concentration dependent manner,
with IC50 ꢁ 6 · 10ꢀ5 M. t-AA at 2.1 · 10ꢀ4 M concen-
tration caused 100% inhibition of PAF 8 · 10ꢀ10 M.
It should be recalled that AA at micromolar concentra-
tions caused platelet aggregation. CP/CPK caused inhi-
bition (100%) of the aggregation induced by t-AA
(2.8 · 10ꢀ4 M), suggesting the involvement of ADP re-
lease. This hypothesis needs further investigation.
References and notes
1. Lipoproteins and Membranes; Vance, D. E., Vance, J. E.,
Eds.; Elsevier: Amsterdam, 2002.
2. Funk, C. D. Science 2001, 294, 1871–1875.
3. Malkowski, M. G.; Ginell, S. L.; Smith, W. L.; Garavito,
R. M. Science 2000, 289, 1933–1937.
4. Chatgilialoglu, C.; Ferreri, C. Acc. Chem. Res. 2005, Web
Release Date: Mar 09, 2005.
5. (a) Chatgilialoglu, C.; Altieri, A.; Fischer, H. J. Am.
Chem. Soc. 2002, 124, 12816–12823; (b) Ferreri, C.;
Costantino, C.; Perrotta, L.; Landi, L.; Mulazzani, Q.
G.; Chatgilialoglu, C. J. Am. Chem. Soc. 2001, 123, 4459–
4468.
6. (a) Ferreri, C.; Sassatelli, F.; Samadi, A.; Landi, L.;
Chatgilialoglu, C. J. Am. Chem. Soc. 2004, 126, 1063–
1072; (b) Ferreri, C.; Faraone-Mennella, M. R.; Formi-
sano, C.; Landi, L.; Chatgilialoglu, C. Free Radical Biol.
Med. 2002, 33, 1516–1526; (c) Chatgilialoglu, C.; Ferreri,
C.; Ballestri, M.; Mulazzani, Q. G.; Landi, L. J. Am.
Chem. Soc. 2000, 122, 4593–4601.
The effect of t-AAME on rabbit platelet aggregation was
not found to be significant. In fact, it did not cause
rabbit platelet aggregation at concentration between
0.2 · 10ꢀ4 M and 6.0 · 10ꢀ4 M indicating that
a
free form of acid is necessary for the aggregation
effect.
Furthermore, it did not cause inhibition of PAF–in-
duced aggregation at any of the concentrations tested
in the range 2.0–4.0 · 10ꢀ4 M. It should be also added
that the respective saturated fatty acid (arachidic acid)
Table 1. Effect of t-AA on rabbit platelet aggregation induced by
4 · 10ꢀ10 M PAF
´ ´
7. Trans Fatty Acids in Human Nutrition; Sebedio, J. L.,
Christie, W. W., Eds.; The Oily: Dundee, 1998.
8. When trans isomers of linoleic acid derived from altered
fats are ingested and metabolized,9 arachidonate moieties
found in tissues contain the 11 and 14 double bonds in the
trans configuration.
t-AA M
Inhibition %
1.5 · 10ꢀ6
1.5 · 10ꢀ5
3.0 · 10ꢀ5
7.5 · 10ꢀ5
2.1 · 10ꢀ4
0
6
24 ( 5)
61 ( 8)
100
9. (a) Beyers, E. C.; Emken, E. A. Biochim. Biophys. Acta
´ ´
1991, 1082, 275–284; (b) Sebedio, J. L.; Vermunt, S. H. F.;
Chardigny, J. M.; Beaufrere, B.; Mensink, R. P.; Arm-
`
strong, R. A.; Christie, W. W.; Niemela¨, J.; Henon, G.;
Riemersma, R. A. Eur. J. Clin. Nutr. 2000, 54, 104–113; (c)
Values are means of three experiments. Standard deviation is given in
parentheses. Aggregation given by 4 · 10ꢀ10 M PAF is considered
100%.